L04AX03 methotrexate
ATC group of level 5 – chemical substance · in plain English: medicines suppressing the immune system, e.g. after a transplant or for autoimmune diseases
This site has the patient leaflet or the SPC of 38 medicines in this group.
- 31 prescription only (POM)
- 5 no longer supplied or not available
Active substance: Methotrexate – all medicines with this substance, also in combinations.
Place in the ATC classification
- L Antineoplastic and immunomodulating agents 1,791 medicines
- L04 Immunosuppressants 545 medicines
- L04A Immunosuppressants 543 medicines
- L04AX Other immunosuppressants 206 medicines
- L04AX03 methotrexate 38 medicines
- L04AX Other immunosuppressants 206 medicines
- L04A Immunosuppressants 543 medicines
- L04 Immunosuppressants 545 medicines
Medicines
Other groups of the same level
- L04AX01 azathioprine 10 medicines
- L04AX02 thalidomide 4 medicines
- L04AX04 lenalidomide 100 medicines
- L04AX05 pirfenidone 14 medicines
- L04AX06 pomalidomide 10 medicines
- L04AX07 dimethyl fumarate 27 medicines
- L04AX08 darvadstrocel 1 medicine
Other names of the ATC group
- Czech: L04AX03 Methotrexát
- French: L04AX03 méthotrexate (voie orale)
- German: L04AX03 Methotrexat
- Spanish: L04AX03 METOTREXATE
- German: L04AX03 Methotrexat
- Italian: L04AX03 METOTREXATO
- Polish: L04AX03 METOTREKSAT
- Turkish: L04AX03 metotreksat
- Portuguese (Brazil): L04AX03 Metotrexato
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group L04AX03
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.
